Phase 2 Study of ADX-038 in Participants With Geographic Atrophy

NCT06990269 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Geographic Atrophy Secondary to Age-related Macular Degeneration

Interventions

DRUG: ADX-038
DRUG: Placebo

Sponsor

ADARx Pharmaceuticals, Inc.